Thanks to advances in techniques for culturing and genetically modifying patient cells, scientists developed myriad stem cell-based treatments for human diseases. Therapeutic success rates for stem cell-based treatments depend on whether scientists can provide the proper structural and molecular cues to form the cell types lacking in patients. In addition, to support successful engraftment, researchers must devise ways to bypass immune rejection.
In this webinar brought to you by The Scientist and ACROBiosystems, and have Kim Vanuytsel and Ryan Flannigan discuss the cutting-edge technologies they incorporate to improve stem cell-based therapies for various disorders, including cancer and infertility.
Topics to be covered:
1. Multi-omic profiling reveals a molecular signature of human fetal liver hematopoietic stem cell engraftment potential
2. Developing in vitro platforms to restore sperm production using 3-D bio-printing